Oncology Gross Profit from 2010 to 2024

TOIIW Stock

USD 0.01 0.01 35.45%

Oncology Institute Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about 45 M in 2024. Gross Profit is the profit The Oncology Institute makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

59.6 M

Current Value

45 M

Quarterly Volatility

11 M

Credit Downgrade

Yuan Drop

Covid

Check Oncology Institute financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncology Institute's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.8 M, Interest Expense of 7.1 M or Selling General Administrative of 67.6 M, as well as many indicators such as Price To Sales Ratio of 0.44, Dividend Yield of 0.0235 or PTB Ratio of 2.51. Oncology financial statements analysis is a perfect complement when working with Oncology Institute Valuation or Volatility modules.

Check out the analysis of Oncology Institute Correlation against competitors.

For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.

Latest Oncology Institute's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of The Oncology Institute over the last few years. Gross profit is a required income statement account that reflects total revenue of The Oncology Institute minus its cost of goods sold. It is profit before Oncology Institute operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Oncology Institute's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oncology Institute's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Oncology Gross Profit Regression Statistics

	Arithmetic Mean	33,393,155
	Geometric Mean	31,995,827
	Coefficient Of Variation	33.05
	Mean Deviation	8,994,220
	Median	26,281,587
	Standard Deviation	11,036,586
	Sample Variance	121.8T
	Range	33.3M
	R-Value	0.81
	Mean Square Error	45.8T
	R-Squared	0.65
	Significance	0.0003
	Slope	1,990,773
	Total Sum of Squares	1705.3T

Oncology Gross Profit History

	2024	45 M
	2023	59.6 M
	2022	52.1 M
	2021	40.8 M
	2020	36.9 M
	2019	29.9 M

Other Fundumenentals of The Oncology Institute

Gross Profit Margin

Oncology Institute Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Intangible Assets	Common Stock	Current Deferred Revenue	Long Term Debt	Short Long Term Debt	Short Term Debt
Total Assets		0.9	0.4	-0.78	0.65	0.91	0.45	0.97	0.98	0.97	-0.91	0.96	-0.85	0.88	-0.94	0.98	-0.97	-0.32
Total Stockholder Equity	0.9		0.18	-0.5	0.43	0.68	0.75	0.78	0.89	0.84	-0.85	0.86	-0.69	0.68	-0.8	0.84	-0.85	-0.5
Net Debt	0.4	0.18		-0.55	0.0	0.69	-0.41	0.49	0.47	0.25	-0.33	0.21	-0.46	0.35	-0.34	0.34	-0.37	0.69
Retained Earnings	-0.78	-0.5	-0.55		-0.83	-0.85	0.06	-0.87	-0.72	-0.82	0.74	-0.79	0.93	-0.88	0.89	-0.84	0.87	0.1
Accounts Payable	0.65	0.43	0.0	-0.83		0.55	0.19	0.71	0.52	0.8	-0.58	0.76	-0.8	0.86	-0.8	0.75	-0.76	-0.54
Net Receivables	0.91	0.68	0.69	-0.85	0.55		0.08	0.96	0.93	0.85	-0.81	0.83	-0.8	0.84	-0.85	0.9	-0.88	0.07
Good Will	0.45	0.75	-0.41	0.06	0.19	0.08		0.25	0.4	0.42	-0.35	0.45	-0.25	0.3	-0.32	0.37	-0.37	-0.76
Total Liab	0.97	0.78	0.49	-0.87	0.71	0.96	0.25		0.95	0.96	-0.87	0.94	-0.87	0.92	-0.94	0.98	-0.96	-0.2
Net Invested Capital	0.98	0.89	0.47	-0.72	0.52	0.93	0.4	0.95		0.92	-0.92	0.93	-0.77	0.79	-0.9	0.95	-0.93	-0.21
Total Current Assets	0.97	0.84	0.25	-0.82	0.8	0.85	0.42	0.96	0.92		-0.91	1.0	-0.86	0.9	-0.98	0.99	-0.98	-0.46
Capital Stock	-0.91	-0.85	-0.33	0.74	-0.58	-0.81	-0.35	-0.87	-0.92	-0.91		-0.94	0.77	-0.69	0.94	-0.94	0.94	0.36
Net Working Capital	0.96	0.86	0.21	-0.79	0.76	0.83	0.45	0.94	0.93	1.0	-0.94		-0.82	0.86	-0.97	0.99	-0.98	-0.48
Intangible Assets	-0.85	-0.69	-0.46	0.93	-0.8	-0.8	-0.25	-0.87	-0.77	-0.86	0.77	-0.82		-0.92	0.92	-0.87	0.91	0.29
Common Stock	0.88	0.68	0.35	-0.88	0.86	0.84	0.3	0.92	0.79	0.9	-0.69	0.86	-0.92		-0.88	0.89	-0.89	-0.31
Current Deferred Revenue	-0.94	-0.8	-0.34	0.89	-0.8	-0.85	-0.32	-0.94	-0.9	-0.98	0.94	-0.97	0.92	-0.88		-0.98	0.99	0.4
Long Term Debt	0.98	0.84	0.34	-0.84	0.75	0.9	0.37	0.98	0.95	0.99	-0.94	0.99	-0.87	0.89	-0.98		-0.99	-0.37
Short Long Term Debt	-0.97	-0.85	-0.37	0.87	-0.76	-0.88	-0.37	-0.96	-0.93	-0.98	0.94	-0.98	0.91	-0.89	0.99	-0.99		0.38
Short Term Debt	-0.32	-0.5	0.69	0.1	-0.54	0.07	-0.76	-0.2	-0.21	-0.46	0.36	-0.48	0.29	-0.31	0.4	-0.37	0.38

Click cells to compare fundamentals

About Oncology Institute Financial Statements

Oncology Institute investors use historical fundamental indicators, such as Oncology Institute's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Oncology Institute. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	59.6 M	45 M
Gross Profit Margin	0.18	0.22

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for Oncology Stock Analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC